Saturday, August 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

Rodolfo Hanigan by Rodolfo Hanigan
February 7, 2026
in Analysis, Banking & Insurance, Mergers & Acquisitions
0
CrossFirst Bankshares Stock
0
SHARES
25
VIEWS
Share on FacebookShare on Twitter

Investors searching for CrossFirst Bankshares stock on the exchange will no longer find it listed. The institution’s independence concluded nearly a year ago when it was fully absorbed into First Busey Corporation. This strategic move creates a significantly larger regional banking entity, reshaping its competitive footprint.

Transaction Details and Market Impact

The merger, initially announced in August 2024, was formally completed on March 1, 2025. This date marked the final trading day for CrossFirst Bankshares equity on the NASDAQ, which occurred on February 28, 2025. All combined operations now trade under the First Busey ticker symbol “BUSE.”

Key details of the deal are as follows:

Should investors sell immediately? Or is it worth buying CrossFirst Bankshares?

  • Acquiring Entity: First Busey Corporation
  • Merger Effective Date: March 1, 2025
  • Listing Symbol: BUSE (NASDAQ)
  • Combined Total Assets: Approximately $20 billion
  • Ownership Stake: Former CrossFirst shareholders now hold an estimated 36.5% of the merged company.

Expanded Footprint and Strategic Rationale

The consolidation has resulted in a financial institution operating 77 banking centers across ten U.S. states. A primary strategic benefit was the immediate enhancement of First Busey’s presence in key metropolitan areas, specifically Kansas City and Dallas/Fort Worth, leveraging CrossFirst’s established network. To streamline operations, the corporate headquarters has been relocated to Leawood, Kansas.

For previous CrossFirst shareholders, the transaction involved an exchange of shares. They are now direct stakeholders in First Busey Corporation and, consequently, eligible for any future dividend distributions from the enlarged group.

The merger was pursued to bolster capabilities in regional markets and diversify revenue streams. All relevant financial results and operational updates for the integrated business segments are now reported exclusively through First Busey Corporation’s publications.

Ad

CrossFirst Bankshares Stock: Buy or Sell?! New CrossFirst Bankshares Analysis from August 8 delivers the answer:

The latest CrossFirst Bankshares figures speak for themselves: Urgent action needed for CrossFirst Bankshares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 8.

CrossFirst Bankshares: Buy or sell? Read more here...

Tags: CrossFirst Bankshares
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Applovin Stock
Analysis

AppLovin’s $40 Billion Wake-Up Call: When a 53% Growth Rate Isn’t Enough

August 8, 2026
Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

August 7, 2026
SANDISK Stock
Analysis

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Next Post
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

Recommended

Biotechnology Stock Bull Market

Analyst Reiterates Buy Rating and 12 Price Target for Shattuck Labs Citing Promising Potential in Biotech Sector

2 years ago
Sangamo Therapeutics Stock

A Regulatory Milestone Sparks Renewed Interest in Sangamo Therapeutics

7 months ago
Diginex Stock

Leadership Shift at Diginex as ESG Software Founder Takes Helm

6 months ago
Novo Nordisk Stock

Novo Nordisk’s Bold Gambit: Price Cuts and Restructuring Amid Market Pressure

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Petrobras Delivers Record-Breaking Quarter, But Investors Keep Their Distance

Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe

AppLovin’s $40 Billion Wake-Up Call: When a 53% Growth Rate Isn’t Enough

Atlassian’s €128.80 Spike: A Profitability Inflection Point Arrives Just as Growth Slows

Amazon’s Three-Trillion-Dollar Moment: A Founder’s Exit, a $220 Billion Wager, and the Fine Print Behind the Record Numbers

The AI Payoff Shifts: Airbnb, SpaceX, and Crypto Show Their Hand

Trending

Novo Nordisk Stock
European Markets

Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline

by SiterGedge
August 8, 2026
0

Novo Nordisk is getting one piece of good news that is easy to count: Wegovy has now...

Nvidia Stock

Nvidia’s Latest Surge Is About More Than a Single Order

August 8, 2026
Plug Power Stock

Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future

August 8, 2026
Petrobras Stock

Petrobras Delivers Record-Breaking Quarter, But Investors Keep Their Distance

August 8, 2026
FALLBACK Stock

Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe

August 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline
  • Nvidia’s Latest Surge Is About More Than a Single Order
  • Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com